Physician profile
Htay Win
NPI 1881642155
$5,726.72
in general payments reported to CMS, 2019-2025
37 companies · $640 in 2025
The $640 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,111 · 2020: $824 · 2021: $716 · 2022: $761 · 2023: $940 · 2024: $734 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,313.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,318.33 | 2019-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $622.23 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $462.61 | 2019-2024 | Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $359.12 | 2019-2023 | Verquvo, Januvia |
| Novartis Pharmaceuticals Corporation | $309.79 | 2019-2023 | |
| Glaxosmithkline, LLC. | $309.61 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| E.R. Squibb & Sons, L.L.C. | $262.85 | 2019-2024 | Eliquis |
| Aimmune Therapeutics, INC. | $180.51 | 2023-2025 | Zenpep |
| Amarin Pharma, INC. | $176.16 | 2020 | |
| Lilly USA, LLC | $170.30 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $164.05 | 2019-2023 | Xifaxan |
| Medtronic Vascular, INC. | $154.54 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $129.76 | 2025 | Zoryve |
| Pfizer INC. | $120.93 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $93.60 | 2020-2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Htay Win listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.